Cambria Cannabis ETF (TOKE)
| Assets | $18.70M |
| Expense Ratio | 0.44% |
| PE Ratio | 19.81 |
| Shares Out | 3.23M |
| Dividend (ttm) | $0.18 |
| Dividend Yield | 3.12% |
| Ex-Dividend Date | Sep 18, 2025 |
| Payout Frequency | Quarterly |
| Payout Ratio | 61.80% |
| Volume | 18,756 |
| Open | 5.72 |
| Previous Close | 5.72 |
| Day's Range | 5.60 - 5.74 |
| 52-Week Low | 3.86 |
| 52-Week High | 6.92 |
| Beta | 0.76 |
| Holdings | 26 |
| Inception Date | Jul 25, 2019 |
About TOKE
Fund Home PageThe Cambria Cannabis ETF (TOKE) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively-managed portfolio of globally-listed companies related to cannabis and hemp. TOKE was launched on Jul 25, 2019 and is issued by Cambria.
Top 10 Holdings
91.55% of assets| Name | Symbol | Weight |
|---|---|---|
| United States Treasury Bills 0% | B.0 11.20.25 | 31.68% |
| First American Treasury Obligations Fund | FXFXX | 10.32% |
| GREEN THUMB INDUSTRIES INC SWAP | n/a | 9.16% |
| Village Farms International, Inc. | VFF | 8.88% |
| GROWN ROGUE INTL INC COM SWAP | n/a | 6.80% |
| Turning Point Brands, Inc. | TPB | 5.33% |
| GLASS HOUSE BRANDS INC SWAP | n/a | 5.22% |
| Cronos Group Inc. | CRON | 4.93% |
| WM Technology, Inc. | MAPS | 4.75% |
| High Tide Inc. | HITI | 4.48% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 18, 2025 | $0.02166 | Sep 19, 2025 |
| Jun 18, 2025 | $0.01097 | Jun 20, 2025 |
| Dec 20, 2024 | $0.14305 | Dec 30, 2024 |
| Sep 20, 2024 | $0.08207 | Sep 30, 2024 |
| Jun 21, 2024 | $0.05207 | Jul 1, 2024 |
| Mar 21, 2024 | $0.06273 | Apr 1, 2024 |
Performance
TOKE had a total return of -4.19% in the past year, including dividends. Since the fund's inception, the average annual return has been -18.37%.
News
Road to Full Cannabis Legalization in the U.S.
Morgan Paxhia discusses the latest trends in the cannabis space. He talks about the road to full cannabis legalization in the U.S. He then goes over the best positioned cannabis stocks.
New Year, No Fear
New years are a time for reflection, especially those that follow tough years filled with challenging lessons. Hopium and corruption (or its close relative, greed) are thriving in these volatile days.
Cannabis REITs: Too Cheap To Get High
The previously high-flying cannabis REITs have been slammed this year on concerns over rent payment from their cannabis cultivator tenants, which have been struggling amid a plunge in wholesale cannab...
Cannabis REITs: Weeding Out The Weak
Cannabis REITs - a perennial performance leader over the past half-decade - have been slammed in 2022 amid concerns over tenant financial health given the sharp re-pricing of risk and tighter financia...
5 developments that cannabis investors did not expect in 2021
2021 has been an interesting year for cannabis investors with lots of positive and negative news. According to New Cannabis Ventures, following were the five developments that cannabis investors hadn'...
Julian Lin's Highest Conviction Idea (Ever)? Cannabis. (Podcast Transcript)
Julian Lin has a new cannabis focused marketplace service, Cannabis Growth Portfolio. We discuss his thoughts on EBITDA, ETFs using total return swaps to own US MSOs, rebalancing away from Canadian op...
Alan Brochstein: The Longer Legislation Takes, The Better For Cannabis Companies (Podcast Transcript)
Alan Brochstein, a friend of the podcast and now a 3peat guest, is the founder of 420 Investor and New Cannabis Ventures. Thoughts on uplisting, the ETF MSOS, volume and valuation issues and confronti...
Alan Brochstein: The Longer Legislation Takes, The Better For Cannabis Companies (Podcast)
Alan Brochstein, a friend of the podcast and now a 3peat guest, is the founder of 420 Investor and New Cannabis Ventures. Thoughts on uplisting, the ETF MSOS, volume and valuation issues and confronti...
Unpacking The Cannabis Industry (Podcast Transcript)
George Jage discusses building out a nascent cannabis industry with trade shows and business media. SAFE banking coming? The unfortunate influence of outside money. Shifting to the CPG industry. Unloc...
Is TOKE A Buy? Evaluating The Cambria Cannabis ETF
TOKE is an ETF run by Meb Faber focusing on the cannabis industry. TOKE boasts the lowest expense ratio among cannabis ETFs.
Current State Of Cannabis (Podcast Transcript)
Emily Paxhia is co-founder and Managing Partner of Poseidon Asset Management, one of the earliest and longest-running funds in the cannabis space. The disappointing political picture around cannabis d...
Master Class In Cannabis Investing, Part 3 (Podcast Transcript)
Our first two Master Classes in cannabis investing with SA authors James Baker and Julian Lin were so successful we're coming back for #3! We discuss why retail cannabis investors are focused too much...
Current State Of Cannabis (Podcast)
Emily Paxhia is co-founder and Managing Partner of Poseidon Asset Management, one of the earliest and longest-running funds in the cannabis space. The disappointing political picture around cannabis d...
Master Class In Cannabis Investing, Part 3 (Podcast)
Our first two Master Classes in cannabis investing with SA authors James Baker and Julian Lin were so successful we're coming back for #3! We discuss why retail cannabis investors are focused too much...
Are Investors Ready For Legal Cannabis? (Podcast)
Are investors ready for the next leg of cannabis legalization and what it does to cannabis companies. That's a question asked by Mike Regan and Colin Ferrian who run MJResearchCo, which provides rigor...
People Are Sick Of Government Telling Them They Can't Buy Cannabis (Podcast)
Happy 4/20! To celebrate, we're joined by Kaelan Castetter and Allan Gandelman, who played an integral part in New York legalizing cannabis. The key to true social equity and why limited licenses stif...
Cannabis Legalization Isn't A Threat, It's An Opportunity (Podcast Transcript)
Cannabis industry as it stands today is 5% of what it's going to be - so says Jay Czarkowski, Founding Partner at Canna Advisors. Chasing competitive licenses, opportunities in MORE Act, MSOs primed t...
Cannabis Legalization Isn't A Threat, It's An Opportunity (Podcast)
Cannabis industry as it stands today is 5% of what it's going to be - so says Jay Czarkowski, Founding Partner at Canna Advisors. Chasing competitive licenses, opportunities in MORE Act, MSOs primed t...
TOKE Unlikely To Make A Name For Itself In The Crowded Cannabis ETF Space
TOKE is yet another competing ETF in the increasingly crowded cannabis landscape.
Global Logistics In Cannabis (Podcast Transcript)
Logistics are an essential part of cannabis, but it's an area where people aren't looking. Yoram Eshel led supply chain and logistics at Teva and now runs Cannabilog, an Israeli company that closes th...
Global Logistics In Cannabis (Podcast)
Logistics are an essential part of cannabis, but it's an area where people aren't looking. Yoram Eshel led supply chain and logistics at Teva and now runs Cannabilog, an Israeli company that closes th...
SPAC Week II: Canndoc And The Parent Company (Podcast Transcript)
Michael Auerbach returns to discuss Subversive's recent deal with leading Israeli cannabis company, InterCure, and gives an update on The Parent Company. Why Subversive pivoted from a REIT to a SPAC, ...
SPAC Week II: Why SPACs Make Sense (Podcast Transcript)
SPAC Week returns with Joe Crouthers, Co-Founder and CEO of Ceres Group Holdings, who discusses why they're focused on the plant-touching side of the sector. Tying cannabis into traditional business. ...
